source
- Study urges regulators to adopt cloud platforms to speed drug approvalsA new study led by Nina Cauchon of Amgen and co-authors, published in the Journal of Pharmaceutical Sciences, calls for broader use of cloud-based platforms by regulatory agencies. The authors arg…
- Verdiva Bio halts mid-stage obesity trial of its GLP-1 pill, citing market evolutionVerdiva Bio, a well-funded private biotech, announced it has terminated one of its Phase 2 trials for its lead oral GLP-1 obesity candidate. The company said the decision reflects a shift in the m…